Vector Vitale IP

Vector Vitale is a biotechnology company focused on developing advanced viral vector technologies to improve the delivery and efficacy of gene therapies. The company specializes in engineering next-generation vectors designed to overcome current limitations in tissue targeting, immune evasion, and manufacturing scalability. By optimizing the delivery vehicle, Vector Vitale aims to expand the therapeutic potential of genetic medicines across a broad range of indications, including rare genetic disorders and oncology. Their intellectual property portfolio centers on novel capsid designs and regulatory elements that enhance transgene expression and safety profiles.